Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (Review)

被引:5
作者
Aunoble, B [1 ]
Sanches, R [1 ]
Didier, E [1 ]
Bignon, YJ [1 ]
机构
[1] Ctr Jean Perrin, Oncol Mol Lab, INSERM, CRI 9502,EA 2145, F-63011 Clermont Ferrand, France
关键词
ovarian cancer; oncogenes; tumor suppressor genes;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer remains the leading cause of death from gynecologic malignancy in Western countries. This cancer results from a succession of genetic alterations involving oncogenes and tumor suppressor genes which have a critical role in normal cell growth regulation. Mutations and/or overexpression of three oncogenes, HER-2/neu, c-myc and K-ras, and of the tumor suppressor gene p53, have frequently been observed in sporadic ovarian cancer. In the context of high risk families, the most frequently involved genes are BRCA1 and BRCA2. We review the function of these different proteins, the incidence of mutations in their genes in carcinogenesis and as potential prognostic factors in sporadic and hereditary ovarian cancer.
引用
收藏
页码:567 / 576
页数:10
相关论文
共 120 条
[1]   ERBB3 AND ERBB2/NEU MEDIATE THE EFFECT OF HEREGULIN ON ACETYLCHOLINE-RECEPTOR GENE-EXPRESSION IN MUSCLE - DIFFERENTIAL EXPRESSION AT THE END-PLATE [J].
ALTIOK, N ;
BESSEREAU, JL ;
CHANGEUX, JP .
EMBO JOURNAL, 1995, 14 (17) :4258-4266
[2]  
Angelopoulou K, 1996, CANCER, V78, P2146, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2146::AID-CNCR15>3.0.CO
[3]  
2-Z
[4]   PREVALENCE OF SERUM ANTIBODIES AGAINST THE P53 TUMOR-SUPPRESSOR GENE PROTEIN IN VARIOUS CANCERS [J].
ANGELOPOULOU, K ;
DIAMANDIS, EP ;
SUTHERLAND, DJA ;
KELLEN, JA ;
BUNTING, PS .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (04) :480-487
[5]   C-MYC AMPLIFICATION IN OVARIAN-CANCER [J].
BAKER, VV ;
BORST, MP ;
DIXON, D ;
HATCH, KD ;
SHINGLETON, HM ;
MILLER, D .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :340-342
[6]  
Berchuck A, 1998, CLIN CANCER RES, V4, P2433
[7]   RECEPTORS FOR HORMONES AND GROWTH-FACTORS AND (ONCO)-GENE AMPLIFICATION IN HUMAN OVARIAN-CANCER [J].
BERNS, EMJJ ;
KLIJN, JGM ;
HENZENLOGMANS, SC ;
RODENBURG, CJ ;
VANDERBURG, MEL ;
FOEKENS, JA .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (02) :218-224
[8]   All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral [J].
Bos, JL .
EMBO JOURNAL, 1998, 17 (23) :6776-6782
[9]  
Brunet JS, 1997, NEW ENGL J MED, V336, P1256
[10]   p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: A molecular and immunohistochemical study [J].
Buttitta, F ;
Marchetti, A ;
Gadducci, A ;
Pellegrini, S ;
Morganti, M ;
Carnicelli, V ;
Cosio, S ;
Gagetti, O ;
Genazzani, AR ;
Bevilacqua, G .
BRITISH JOURNAL OF CANCER, 1997, 75 (02) :230-235